JavaScript disabled. Please enable JavaScript to use My News, My Clippings, My Comments and user settings.

If you have trouble accessing our login form below, you can go to our login page.

If you have trouble accessing our login form below, you can go to our login page.

Party drug treats depression


Luke Malone

Happy pills? ... research into ketamine offers hope to depression sufferers.

Happy pills? ... research into ketamine offers hope to depression sufferers. Photo: Viki Yemettas

In January, researchers from Houston's Ben Taub General Hospital announced their groundbreaking research into a new drug-based treatment for depression. It was, they said, ridding the clinically depressed of their symptoms within a matter of hours and showed a success rate of 70-90 per cent – making it one of the biggest medical developments since the advent of antidepressants in the late 1950s.

"Everything since then has been essentially incremental," said study leader Sanjay Mathew, associate professor of psychiatry and behavioural sciences at Baylor College of Medicine. "It's a completely different mechanism. And the focus is on really rapidly helping someone get out of a depressive episode."

This new mechanism isn't the result of a recently discovered chemical compound but the reapplication of an existing drug – ketamine. Used in both human and veterinary science as an anaesthetic agent, it's also taken recreationally among drug users who seek out its dissociative, euphoric and hallucinatory effects.

A completely separate class of medication to traditional antidepressants, which work on serotonin or adrenaline, ketamine works on the glutamate receptor system and presents an exciting paradigm shift in the treatment of depression.

The recent study is a follow-up to 2006 research conducted by the National Institute of Mental Health. With the success of these studies, researchers from the University of New South Wales' School of Psychiatry and the Black Dog Institute – in conjunction with clinical pharmacologists from The University of Adelaide and the University of Otago – have embarked on the first Australian investigation.

"When I read the studies I was bowled over by the incredible response to ketamine that was being reported. It was almost too good to be true," said study leader Professor Colleen Loo. "We thought, gee, if they're that fantastic we should really try and see for ourselves. What the conventional antidepressants were achieving in two-to-four weeks they were achieving in 24 hours, sometimes less. It was unbelievable."

Not only is the response time in stark contrast to drugs currently on the market, it's proving to be more effective in relieving participants of their depressive symptoms. Whereas traditional antidepressants can be a bit hit and miss with only 30-40 per cent of patients responding to the initial prescribed medication and dosage, ketamine studies are showing early success rates of more than double that. Though long-term effectiveness is yet to be established, the success rate and its relative speed is promising – especially for individuals presenting with severe depressive symptoms.

"One of the first things is that people can be really unwell. They can be suicidal or they're not eating or drinking and it's a problem if you can't turn them around for two-to-four weeks... If you have a treatment that can get people well quickly that is very beneficial," said Loo. "The other problem of waiting up to four weeks is that you're not sure how you're going to respond to the drug. You could take this one for four weeks and then you might have to take a different one and again you might have to wait four weeks to see if that's going to work before you try the next one. This can start to become quite drawn out and begin to discourage patients."

Another proposed benefit to the use of ketamine is the relative absence of serious side effects. Electroconvulsive therapy has so far been the only effective tool to help combat clinical depression in patients who haven't responded to medication. Though it's a viable treatment, studies show ECT can cause memory loss and other adverse cognitive effects. Because the ketamine study is looking at short-term, low-dose use the side effects are minimal, and there have even been reports of people who have failed with ECT responding to ketamine.

"What we are finding is that at the higher doses you can get transient psychonautic effects. I think this is what people who abuse it are looking for. You can feel a bit disassociated, a bit unreal, things look distorted and, at higher doses, you can actually start to have hallucinations," said Loo. "We're using lower doses than what people do who abuse so people aren't actually having hallucinations, they're getting that milder unreal feeling but these are transient and go away after half an hour or so. On the other side it can affect your blood pressure and heart rate so we monitor that very carefully. In the conditions where we do it we're looking at single doses, not the large number of repeated doses of people who abuse it."

Just as illicit drugs such as LSD, ecstasy and marijuana have been used in a medical context but remain dangerous in terms of recreational use so too is ketamine. Loo explains that they administer the drug intravenously in a hospital setting once a week over six weeks in order to carefully control both dose and rate, and he stresses that individuals who self-administer run the risk of more serious side effects.

"People aren't just sitting on a chair in a ward somewhere drinking something; it's under very careful, medically monitored conditions," she said. "You need to remember that ketamine is used as a full anaesthetic agent so it's not safe to just draw something and inject it into yourself at any old rate... You could end up increasing your heart rate to the point where you have a stroke."

With Australian trials underway since February, Dr Rosalyn Lai, a research fellow at The New South Wales Institute of Psychiatry and fellow study author, says the response has been promising.

"The results have been quite positive so far, we've had four people complete the trial so far, and of the four people who have gone through, all of them have achieved some level of response," she said. "What I mean by response is that they've had a drop of at least 50 per cent in their mood rating scores. It's been very, very exciting to see."

Loo adds that more investigation is in order before ketamine is ready for clinical use. Though that could be as soon as a few years away, she says researchers need to see if it has a long-lasting response before it can be marketed as a useful tool in the treatment of clinical depression. Even then, she doesn't foresee it replacing antidepressants currently on the market.

"In its current form ketamine needs to be given intravenously in a hospital setting under careful medical supervision, so it's a lot more complicated than giving someone a script and saying, 'Go home and take this pill.' Unless ketamine can be developed into a form that can be given safely orally and still be effective, and we're not there yet, I don't see it replacing antidepressants," she said. "It's my opinion that we don't need to replace A with B or C with D. Having a whole suite of treatment options, so that we have more to choose from, means we can better match the treatment to the clinical situation and the patient. I think that's to the advantage of everyone."

For more information on the study, or to inquire about taking part, visit the Black Dog Institute website.


  • For someone who has been on antidepressants for over 15 years for major depression this is good and bad news for me. Due to having a muscular dystrophy type illness I wasn't allowed to take part in this trial, plus another trial involving transcranial magnetic stimulation. I would for go any of the risks to have the chance of feeling positive and happy in my life and not to be on my current medication which is not very effective.

    Date and time
    June 19, 2012, 11:39AM
    • Good luck Andrew, I know it can be tough. This could be an exciting advancement. Hopefully you will be allowed to try it after the testing period. I know the relief when you find a strategy that works. It's like your eyes being opened. I wish this for you.

      Susan C
      Date and time
      June 19, 2012, 12:47PM
    • I feel for you Andrew and very much hope a better treatment, such as this, becomes available sooner rather than later.

      I went through a number of years suffering pretty severe depression and the medications approved for treatment are so hit and miss as to be a joke, GP's and psychiatrists can be extremely whimsical on results and one eyed on the whole traditional antidepressant treatment regime. It took me years to get onto the right one for me and that was in spite of their help. They really don't know how or why they work and it's simply treatment roulette.

      I have beaten the black dogs finally, however now have a non psychological/psychiatric chronic and disabling illness involving quite severe pain amongst many other nasty symptoms. The pain medications I'm on, and the only ones that give relief, are of a narcotic type. These have terrible "side effects", most especially on bowel function.
      I have found that by smoking marijuana I get substantial pain relief, a much better appetite and much improved GI function and am able to use half the amount of narcotic than I need otherwise - yet I am engaging in a crime when I buy, posess and use it.
      It is the same for many other illegal/illicit drugs and medical conditions. The obsession with illicit drugs appears to be based on their other effects, and with marijuana, yes, I also get a high from it - how evil! I can't and don't drink alcohol by the way and in fact don't much like the feeling of being tipsy anyways.
      There are many illicit drugs with either proven or highly indicated uses way beyond "abuse". The absurdity and disgrace is that the ill are denied these benefits for arbitrary reasons and can't be studied.

      Date and time
      June 19, 2012, 6:02PM
    • tried MAOIs? i struggled for decades on ssri/snri and a new dr tried maoi. a year of playing with doses, and now Im the best ive ever been. Not for everyone of course, but no drug is. Its worth the (medically supervised) trial and error to find out what is right for YOUR body!

      Date and time
      June 19, 2012, 8:24PM
    • Mate I hope you can get the relief you are looking for. It is sad to see that beaurocracy is throwing logs under your progress.

      Best of luck and chin up, perseverance is always a good thing and I am sure you will find the peace you are after.

      Date and time
      June 19, 2012, 11:06PM
  • Oh we've stumbled on another "illegal" substance that may have some benefit to mankind at large!

    "LSD, ecstasy and marijuana.....but remain dangerous in terms of recreational use so too is ketamine" How many deaths per year are due to using these "dangerous drugs?"

    Alcohol is the most dangerous legal drug available with tobacco a close second, its about time Australia started really looking at the benefits of these drugs and decriminalise their use.

    Date and time
    June 19, 2012, 11:42AM
    • I also picked this up.
      As usual it is the reporter not the medical physcian saying these illigal drugs are dangerous. This is typical media scare mongering.

      The deaths caused from LSD, Ecstacy, Marijuana, and ketimine combined is a tiny fraction of the deaths & diseases caused by alcohol anyway you choose to look at it.

      Date and time
      June 19, 2012, 12:55PM
    • @ Mayday. If you have a really big night out drinking, generally the worst you are going to achieve is passing out, spewing and having a hangover. If you have a really big night out on LSD or Ecstasy, you can easily wind up dead… A slight but subtle difference, maybe I should smoke some drugs, then I will be able to see a clear link between the legal and illegal drugs as you obviously do.

      Date and time
      June 19, 2012, 4:00PM
    • Hear, hear.

      Date and time
      June 19, 2012, 4:04PM
    • @Realist.... you don't have much 'hands on experience' with drugs, do you?

      Date and time
      June 19, 2012, 5:14PM

More comments

Comments are now closed

HuffPost Australia

Follow Us on Facebook

Featured advertisers


Capricorn horoscope

Trust others to think for themselves. Don't be snobbish about what seems obvious. Everyone learns at their own pace, including you.

...find out more here